SunRock Biopharma, S.L
Pablo Garrido Cuesta is a highly experienced professional in the field of cancer research and metabolism, currently serving as Chief Scientific Officer and Project Manager at SunRock Biopharma, S.L. since July 2017. Prior to this role, Pablo held a position as a Postdoctoral Researcher at NUI Galway from March 2014 to June 2017 and briefly contributed as an Invited Researcher at the National Cancer Institute in August 2016. Pablo's academic journey culminated in a PhD in cancer metabolism from Universidad de Oviedo, where research focused on the insulin signaling pathway in breast cancer. Additionally, Pablo has experience as a PhD student at Karolinska Institutet, investigating the impact of hormones on glucose and lipid metabolism. Pablo completed a Bachelor of Applied Science in Biology at Universidad de Oviedo in 2008.
This person is not in any teams
This person is not in any offices
SunRock Biopharma, S.L
SunRock is a biopharmaceutical company, developing sophisticated therapeutic antibodies under innovative formats antibodies to treat incurable cancer. SunRock, working under an open innovation system, aims to develop the different programs from early discovery to the completion of phase I clinical trials. SunRock has developed an extensive portfolio of bispecific molecules targeting CCR9 and HER3 raising high expectation among the key players of the industry.